There are various triggers of acute exacerbation of asthma. Bronchospasm and airway inflammation with edema and mucus production are key physiologic factors leading to clinical symptoms. β-Agonists and other bronchodilators target bronchospasm while corticosteroids reduce the inflammatory response by inhibiting the activation of inflammatory cells and by reducing mediator production, microvascular leakage, and mucus formation.